##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##SAMPLE=<ID=NA12878_03,Gender=female,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##PIPELINE=megSAP 0.1-742-ged8ba02
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	gnomAD_sub	ESP_sub	gnomAD	phyloP	PolyPhen	Sift	OMIM	fathmm-MKL	CADD	REVEL	ClinVar	HGMD	COSMIC	NGSD_hom	NGSD_het	classification	classification_comment	validation	gene_info
chr1	62732421	62732421	T	C	het		QUAL=13777;DP=857;AF=0.52;MQM=60	KANK4	missense_variant	KANK4:NM_181712.4:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala		rs11207949	0.3055	0.284	0.284	0.2449	2.3800	T	T,T,T								50	368				LINC00115 (inh=n/a pLI=n/a)
chr1	62739198	62739198	G	A	het		QUAL=2166;DP=140;AF=0.49;MQM=60	KANK4	synonymous_variant	KANK4:NM_181712.4:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526Ser		rs17855078	0.2506	0.308	0.308	0.3309											114	480				LINC00115 (inh=n/a pLI=n/a)
chr1	120458004	120458004	A	T	het		QUAL=2123;DP=127;AF=0.55;MQM=60	NOTCH2	synonymous_variant	NOTCH2:NM_024408.3:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447Gly		rs6685892	0.1925	0.129	0.129	0.1038				600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];							11	217				SAMD11 (inh=n/a pLI=0.00)
chr1	120611964	120611964	G	C	het		QUAL=22127;DP=1927;AF=0.38;MQM=58	NOTCH2	missense_variant	NOTCH2:NM_024408.3:missense_variant:MODERATE:exon1/34:c.57C>G:p.Cys19Trp,NOTCH2:NM_001200001.1:missense_variant:MODERATE:exon1/22:c.57C>G:p.Cys19Trp		rs11810554	0	0.406	0.406	0	0.7660	T,T	.,T	600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];						COSM132738	5	1181				SAMD11 (inh=n/a pLI=0.00), NOC2L (inh=n/a pLI=0.00)
chr1	120612006	120612006	G	A	het		QUAL=24336;DP=2004;AF=0.39;MQM=58	NOTCH2	synonymous_variant	NOTCH2:NM_024408.3:synonymous_variant:LOW:exon1/34:c.15C>T:p.Arg5Arg,NOTCH2:NM_001200001.1:synonymous_variant:LOW:exon1/22:c.15C>T:p.Arg5Arg		rs4021006	0.394	0.422	0.422	0	1.0740			600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				RCV000173523.1 [uncertain significance]; 		COSM1320072	1	1178				NOC2L (inh=n/a pLI=0.00)
chr2	215595164	215595164	G	A	het	pred_pathogenic_2	QUAL=334;DP=27;AF=0.44;MQM=60	BARD1	missense_variant,non_coding_exon_variant	BARD1:NM_000465.3:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys,BARD1:NM_001282543.1:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys,BARD1:NM_001282545.1:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys,BARD1:NM_001282548.1:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys,BARD1:NM_001282549.1:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys,BARD1:NR_104212.1:non_coding_exon_variant:MODIFIER:exon9/10:n.1965C>T:,BARD1:NR_104215.1:non_coding_exon_variant:MODIFIER:exon8/9:n.1908C>T:,BARD1:NR_104216.1:non_coding_exon_variant:MODIFIER:exon9/10:n.1164C>T:		rs3738888	0.0054	0.0079,0.0123	0.0079,0.0123	0.0078	5.1650	T	D,D,D,D	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				RCV000130975.3 [benign]; 	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1]; 	COSM3782110, COSM3782109	0	12			n/a (1xTP, 0xFP)	NOC2L (inh=n/a pLI=0.00)
chr2	215632255	215632255	C	T	het		QUAL=3342;DP=109;AF=0.55;MQM=60	BARD1	missense_variant,intron_variant,non_coding_exon_variant	BARD1:NM_000465.3:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met,BARD1:NM_001282543.1:missense_variant:MODERATE:exon5/10:c.1462G>A:p.Val488Met,BARD1:NM_001282545.1:intron_variant:MODIFIER:exon2/6:c.216-14976G>A:,BARD1:NM_001282548.1:intron_variant:MODIFIER:exon1/5:c.159-14976G>A:,BARD1:NM_001282549.1:intron_variant:MODIFIER:exon3/4:c.364+24766G>A:,BARD1:NR_104212.1:non_coding_exon_variant:MODIFIER:exon5/10:n.1512G>A:,BARD1:NR_104215.1:non_coding_exon_variant:MODIFIER:exon4/9:n.1455G>A:,BARD1:NR_104216.1:non_coding_exon_variant:MODIFIER:exon5/10:n.711G>A:		rs2070094	0.3662	0.378	0.378	0.2758	-5.2640	T	T,T	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				RCV000128872.2 [benign]; 	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1]; 	COSM3757929, COSM3757930	192	669				KLHL17 (inh=n/a pLI=0.00)
chr2	215674224	215674224	G	A	het	pred_pathogenic_1	QUAL=10769;DP=775;AF=0.49;MQM=60	BARD1,LOC101928103	missense_variant,upstream_gene,non_coding_exon_variant	BARD1:NM_000465.3:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser,BARD1:NM_001282543.1:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser,BARD1:NM_001282545.1:missense_variant:MODERATE:exon1/7:c.70C>T:p.Pro24Ser,BARD1:NM_001282548.1:missense_variant:MODERATE:exon1/6:c.70C>T:p.Pro24Ser,BARD1:NM_001282549.1:missense_variant:MODERATE:exon1/5:c.70C>T:p.Pro24Ser,LOC101928103:NR_110292.1:upstream_gene:MODIFIER::n.-1G>A:,BARD1:NR_104212.1:non_coding_exon_variant:MODIFIER:exon1/10:n.212C>T:,BARD1:NR_104215.1:non_coding_exon_variant:MODIFIER:exon1/9:n.212C>T:,BARD1:NR_104216.1:non_coding_exon_variant:MODIFIER:exon1/10:n.212C>T:		rs1048108	0.3313	0.367	0.367	0.3474	0.9680	T	T,D	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				RCV000162363.1 [benign]; 	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM442275, COSM1482743	191	693				KLHL17 (inh=n/a pLI=0.00)
chr3	10085536	10085536	A	G	het		QUAL=3006;DP=292;AF=0.43;MQM=60	FANCD2	synonymous_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0	0.122	0.122	0				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];						COSM3759562, COSM3759563	0	474				PLEKHN1 (inh=n/a pLI=0.00)
chr3	10106532	10106532	C	T	het		QUAL=1466;DP=74;AF=0.64;MQM=60	FANCD2	missense_variant	FANCD2:NM_033084.3:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:NM_001018115.1:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu		rs3864017	0	0.155	0.155	0	-0.1810	T	T,T,T,T	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				RCV000120989.1 [not provided]; 			32	430				PERM1 (inh=n/a pLI=n/a)
chr3	10138069	10138069	T	G	het		QUAL=11320;DP=767;AF=0.47;MQM=60	FANCD2,FANCD2OS	synonymous_variant,intron_variant	FANCD2:NM_033084.3:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366Leu,FANCD2:NM_001018115.1:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2OS:NM_173472.1:intron_variant:MODIFIER:exon2/2:c.*43+7813A>C:		rs2272125	0.2422	0.187	0.187	0.1647				613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];					CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2]; 	COSM3759565, COSM3759566	42	444				PERM1 (inh=n/a pLI=n/a)
chr3	142178144	142178144	C	T	het		QUAL=1272;DP=77;AF=0.55;MQM=60	ATR	missense_variant	ATR:NM_001184.3:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln		rs2229032	0.1022	0.132	0.132	0.1578	0.0440	T	T,T	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000123787.1 [benign]; RCV000145330.1 [benign]; 		COSM149485	37	414				HES4 (inh=n/a pLI=0.00)
chr3	142188337	142188337	A	C	het	pred_pathogenic_1	QUAL=11942;DP=680;AF=0.56;MQM=60	ATR	missense_variant	ATR:NM_001184.3:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp		rs28910273	0.002	0.0033	0.0033	0.0069	2.3460	T	T,D	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000145327.1 [uncertain significance]; 			0	17				ISG15 (inh=AR pLI=0.01)
chr3	142217537	142217537	A	G	het		QUAL=4602;DP=347;AF=0.51;MQM=60	ATR	synonymous_variant	ATR:NM_001184.3:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820Tyr		rs2227932	0.0669	0.093	0.093	0.1062				601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000123788.1 [benign]; RCV000145320.1 [likely benign]; 			19	255				ISG15 (inh=AR pLI=0.01)
chr7	142460313	142460313	T	C	hom		QUAL=4873;DP=163;AF=0.99;MQM=60	PRSS1	synonymous_variant	PRSS1:NM_002769.4:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162Asp		rs6666	0.3966	0.369	0.369	0				276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];					CM086253 [CLASS=DP MUT=REF PHEN="Pancreatitis chronic association with" GENE=PRSS1]; 	COSM4161889	157	933				AGRN (inh=AR pLI=0.17)
chr7	142460865	142460865	T	C	hom		QUAL=10084;DP=347;AF=1.00;MQM=59	PRSS1	synonymous_variant	PRSS1:NM_002769.4:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246Asn		rs6667	0.3938	0.504	0.504	0				276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];							443	685				AGRN (inh=AR pLI=0.17)
chr9	98209594	98209594	G	A	het	pred_pathogenic_1	QUAL=1349;DP=67;AF=0.69;MQM=60	PTCH1	missense_variant	PTCH1:NM_000264.3:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu,PTCH1:NM_001083607.1:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083606.1:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083604.1:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083605.1:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083602.1:missense_variant:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu,PTCH1:NM_001083603.1:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu		rs357564	0.3968	0.38	0.38	0.3298	9.4050	T	D,D,D,D,D,D,D,D	601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				RCV000034575.1 [benign]; RCV000078463.5 [benign]; 	CM056376 [CLASS=DP MUT=REF PHEN="Skin cancer association with" GENE=PTCH1]; 	COSM1638395, COSM1638394, COSM1638396, COSM1638397	198	688				INTS11 (inh=n/a pLI=0.00)
chr9	98232224	98232224	A	-	het		QUAL=705;DP=57;AF=0.53;MQM=60	PTCH1,LOC100507346	splice_region_variant&intron_variant,non_coding_exon_variant	PTCH1:NM_000264.3:splice_region_variant&intron_variant:LOW:exon12/23:c.1729-11delT:,PTCH1:NM_001083607.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083606.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083604.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083605.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083602.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1531-11delT:,PTCH1:NM_001083603.1:splice_region_variant&intron_variant:LOW:exon12/23:c.1726-11delT:,LOC100507346:NR_038982.1:non_coding_exon_variant:MODIFIER:exon4/4:n.1887delA:			0	0.0014	0.0014	0.0018				601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];							0	3				INTS11 (inh=n/a pLI=0.00)
chr11	108183167	108183167	A	G	hom		QUAL=14153;DP=443;AF=1.00;MQM=60	ATM	missense_variant	ATM:NM_000051.3:missense_variant:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser		rs659243	1	1	1	0	-1.0580	T	T,T	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				RCV000128947.1,RCV000120149.2 [benign,benign]; 			2669	0				DVL1 (inh=AD pLI=0.16)
chr15	43707808	43707808	A	T	het		QUAL=1980;DP=130;AF=0.47;MQM=60	TP53BP1,RNU6-28P	synonymous_variant,intron_variant	TP53BP1:NM_001141980.1:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:NM_001141979.1:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:NM_005657.2:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686Ser,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+24389A>T:		rs2230451	0.1286	0.163	0.163	0.19										COSM3754329	73	430				CCNL2 (inh=n/a pLI=0.10)
chr15	43724646	43724646	T	G	hom		QUAL=19907;DP=624;AF=1.00;MQM=60	TP53BP1,RNU6-28P	missense_variant,intron_variant	TP53BP1:NM_001141980.1:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:NM_001141979.1:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:NM_005657.2:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+41227T>G:		rs2602141	0.5264	0.375	0.375	0.3036	3.2610	T	T,T,T,T						CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3754330	168	557				CCNL2 (inh=n/a pLI=0.10)
chr15	43748304	43748304	A	G	hom		QUAL=30130;DP=949;AF=1.00;MQM=60	TP53BP1,RNU6-28P	synonymous_variant,intron_variant	TP53BP1:NM_001141980.1:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:NM_001141979.1:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:NM_005657.2:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829Asp,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+64885A>G:		rs690367	0.5262	0.374	0.374	0.3032										COSM3754331	169	554				ANKRD65 (inh=n/a pLI=n/a)
chr15	43762196	43762196	C	T	het	pred_pathogenic_1	QUAL=3865;DP=203;AF=0.59;MQM=60	TP53BP1,RNU6-28P	missense_variant,intron_variant	TP53BP1:NM_001141980.1:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:NM_001141979.1:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:NM_005657.2:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+78777C>T:		rs689647	0.3824	0.206	0.206	0.113	1.1390	T	D,D,D,D,T						CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1]; 	COSM3754332	26	263				ANKRD65 (inh=n/a pLI=n/a)
chr15	43767774	43767774	G	C	hom		QUAL=3608;DP=116;AF=1.00;MQM=60	TP53BP1,RNU6-28P	missense_variant,intron_variant	TP53BP1:NM_001141980.1:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:NM_001141979.1:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:NM_005657.2:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu,RNU6-28P:NR_046489.1.2:intron_variant:MODIFIER:exon4/4:n.34+84355G>C:		rs560191	0.5258	0.374	0.374	0.3029	0.2260	T	T,T,T,T,T						CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3744615	169	554				ANKRD65 (inh=n/a pLI=n/a)
chr16	89838078	89838078	A	G	het		QUAL=15879;DP=1034;AF=0.48;MQM=60	FANCA	splice_region_variant&intron_variant	FANCA:NM_000135.2:splice_region_variant&intron_variant:LOW:exon23/42:c.2151+8T>C:,FANCA:NM_001286167.1:splice_region_variant&intron_variant:LOW:exon23/42:c.2151+8T>C:		rs1800340	0.5599	0.431	0.431	0.3077				607139 [FANCA (confirmed) Fanconi anemia,complementation group A];							161	661				VWA1 (inh=n/a pLI=0.03)
chr16	89849480	89849480	C	T	hom		QUAL=6699;DP=199;AF=1.00;MQM=60	FANCA	missense_variant	FANCA:NM_000135.2:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser,FANCA:NM_001286167.1:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser		rs2239359	0.624	0.499	0.499	0.381	-0.0380	T	T	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				RCV000120917.1 [not provided]; 	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		271	763				ATAD3B (inh=n/a pLI=0.00)
chr16	89866043	89866043	T	C	het		QUAL=11520;DP=724;AF=0.50;MQM=60	FANCA	missense_variant	FANCA:NM_000135.2:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001286167.1:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001018112.1:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala		rs7190823	0.6905	0.517	0.517	0.3937	0.4020	T	T,T,T,T	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				RCV000120967.1 [not provided]; 	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		256	731				ATAD3B (inh=n/a pLI=0.00)
chr17	29553485	29553485	G	A	hom		QUAL=2516;DP=83;AF=1.00;MQM=60	NF1	synonymous_variant,downstream_gene_variant	NF1:NM_001042492.2:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678Pro,NF1:NM_000267.3:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678Pro,NF1:NM_001128147.2:downstream_gene_variant:MODIFIER::c.*2165G>A:		rs2285892	0.4968	0.382	0.382	0.2891				613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				RCV000162648.1 [benign]; 			138	634				ATAD3A (inh=AR+AD pLI=0.04)
chr19	17389648	17389648	C	T	het		QUAL=1535;DP=106;AF=0.47;MQM=60	BABAM1,ANKLE1	splice_region_variant&intron_variant,upstream_gene	BABAM1:NM_001033549.2:splice_region_variant&intron_variant:LOW:exon8/8:c.787-6C>T:,BABAM1:NM_001288756.1:splice_region_variant&intron_variant:LOW:exon8/8:c.787-6C>T:,BABAM1:NM_001288757.1:splice_region_variant&intron_variant:LOW:exon5/5:c.562-6C>T:,BABAM1:NM_014173.3:splice_region_variant&intron_variant:LOW:exon8/8:c.787-6C>T:,ANKLE1:NM_152363.5:upstream_gene:MODIFIER::c.-115C>T:,ANKLE1:NM_001278443.1:upstream_gene:MODIFIER::c.-115C>T:,ANKLE1:NM_001278444.1:upstream_gene:MODIFIER::c.-115C>T:,ANKLE1:NM_001278445.1:upstream_gene:MODIFIER::c.-206C>T:,ANKLE1:NR_103530.1:upstream_gene:MODIFIER::n.-1C>T:		rs10406920	0.1118	0.148	0.148	0.1799											33	301				CDK11B (inh=AD pLI=0.73)
chr19	17389704	17389704	G	A	het		QUAL=7841;DP=526;AF=0.47;MQM=60	BABAM1,ANKLE1	synonymous_variant,upstream_gene	BABAM1:NM_001033549.2:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:NM_001288756.1:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:NM_001288757.1:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204Lys,BABAM1:NM_014173.3:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279Lys,ANKLE1:NM_152363.5:upstream_gene:MODIFIER::c.-115G>A:,ANKLE1:NM_001278443.1:upstream_gene:MODIFIER::c.-115G>A:,ANKLE1:NM_001278444.1:upstream_gene:MODIFIER::c.-115G>A:,ANKLE1:NM_001278445.1:upstream_gene:MODIFIER::c.-206G>A:,ANKLE1:NR_103530.1:upstream_gene:MODIFIER::n.-1G>A:		rs8170	0.1124	0.152	0.152	0.1811									CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1]; 	COSM438891, COSM438892	33	302				CDK11B (inh=AD pLI=0.73)
